Porcine-derived surfactant treatment of severe bronchiolitis

Acta Anaesthesiologica Scandinavica

Volumn 42, Issue 7, 1998, Pages 805-810

  Luchetti, M ^a,b   Casiraghi, G ^a   Valsecchi, R ^a   Galassini, E ^a   Marraro, G ^a  

^a Fatebenefratelli Ophthalmiatric H ^*  (Italy)

^b FATEBENEFRATELLI HOSPITAL   (Italy)

Author keywords

Bronchiolitis; Children; Mechanical ventilation; Pulmonary surfactant

Indexed keywords

LUNG SURFACTANT; LUNG SURFACTANT EXTRACT;

ARTICLE; ARTIFICIAL VENTILATION; BRONCHIOLITIS; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GAS EXCHANGE; HUMAN; INFANT; INHALATIONAL DRUG ADMINISTRATION; INTENSIVE CARE; MALE; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0031872574     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-6576.1998.tb05326.x     Document Type: Article

References (23)

1. Hemming VG. Viral respiratory diseases in children: classification, etiology, epidemiology, and risk factors. J Pediatr 1994: 124: S13-S16.
2. Dargaville PA, South M, MacDouglas PN. Surfactant abnormalities in infants with severe viral bronchiolitis. Arch Dis Child 1996: 75: 133-136.
3. Macklem PT, Proctor DF, Hogg JC. The stability of peripheral airways. Respir Physiol 1970: 8: 191-203.
4. Kimpen JLL. Treatment of respiratory syncytial virus bronchiolitis: hope and despair. In: Tibboel D, van der Voort E, eds. Intensive care in childood. A challenge to the future. Berlin: Springer Verlag, 1996: 354-361.
5. Lachmann B. Open up the lung and keep the lung open. Intensive Care Med 1992: 18: 319-321.
6. Lachmann B. Surfactant replacement. Applied Cardiopulmonary Pathophysiology 1989: 3: 3-11.
7. Marraro G, Foresti B, Casiraghi G, Riva A. Surfactant treatment of respiratory failure in children. In: Bevilacqua G et al., eds. Surfactant in clinical practice. Chur, Switzerland: Harwood Academic Publishers 1992: 173-180.
8. Marraro G, Casiraghi G, Monici-Preti PA, Vignati D. Supplementary surfactant in ARDS infants. Pediatr Res 1993: 33: 37A.
9. Sun B, Curstedt T, Robertson B. Surfactant inhibition in experimental meconium aspiration. Acta Paediatr Scand 1993: 82: 182-189.
10. Halliday HL, Speer CP, Robertson B. Treatment of severe meconium aspiration syndrome with porcine surfactant. Eur J Pediatr 1996: 155: 1047-1051.
11. Lachmann B. Surfactant treatment for lung diseases other than the infant respiratory distress syndrome. In: Jobe AH, Taeusch HW, eds. Surfactant treatment of lung diseases. Report of the 96th Ross Conference on Paediatric Research. Columbus, Ohio, USA: Ross Laboratories, 1988: 123-128.
12. Sweet C, Smith H. Pathogenicity of influenza virus. Microbiol Rev 1980: 44: 303-330.
13. Lachmann B, Hallman M, Bergmann KC. Respiratory failure following anti-lung serum: study on mechanisms associated with surfactant system damage. Exp Lung Res 1987: 12: 163-180.
14. Greenfield IJ, Ebert PA, Benson DW. Effect of positive pressure ventilation on surface tension of lung extracts. Anesthesiology 1964: 25: 312-316.
15. Holm BA, Matalon S, Finkelstein JH, Notter RH. Type II pneumocite changes during hyperoxic lung injury and recovery. J Appl Physiol 1988: 65: 2672-2678.
16. Batenburg JJ. Biosynthesis and secretion of pulmonary surfactant. In: Robertson B et al., eds. Pulmonary surfactant. Amsterdam: Elsevier, 1989: 237-240.
17. Jarstrand C. Role of surfactant in the pulmonary defence system. In: Robertson B, van Golde LMG, Batenburg JJ, eds. Pulmonary surfactant. Amsterdam: Elsevier 1984: 187-201.
18. Huber G, Mullane J, La Force FM. The role of alveolar lining material in antibacterial defenses of the lung. Bull Eur Physiopath Resp 1976: 12: 178-179.
19. Lachmann B, Bergmann KC. Surfactant replacement improves thorax-lung compliance and survival rate in mice with influenza infection. Am Rev Respir Dis 1987: 135: A6.
20. Van Daal GJ, So KL, Gommers D, Eijking EP, Fievez RB, Sprenger MJ et al. Intratracheal surfactant administration restores gas exchange in experimental adult respiratory distress syndrome associated with viral pneumonia. Anesth Analg 1991: 72: 589-595.
21. Van Daal GJ, Bos JAH, Eijking EP, Gommers D, Hannappel E, Lachmann B. Surfactant replacement therapy improves pulmonary mechanics in endstage influenza A pneumonia in mice. Am Rev Respir Dis 1992: 145: 859-863.
22. Matalon S, Holm BA, Notter RH. Mitigation of pulmonary hyperoxic injury by administration of exogenous surfactant. J Appl Physiol 1987: 62: 756-761.
23. Saugstad OD. Oxygen toxicity in the neonatal period. Acta Paediatr Scand 1990: 79: 881-892.